Metastatic Melanoma Patient-Derived Xenografts Respond to MDM2 Inhibition as a Single Agent or in Combination with BRAF/MEK Inhibition
转移性黑色素瘤患者来源的异种移植瘤对MDM2抑制剂单药治疗或与BRAF/MEK抑制剂联合治疗均有反应
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-19-1895
Shattuck-Brandt, Rebecca L; Chen, Sheau-Chiann; Murray, Emily; Johnson, Christopher Andrew; Crandall, Holly; O'Neal, Jamye F; Al-Rohil, Rami Nayef; Nebhan, Caroline A; Bharti, Vijaya; Dahlman, Kimberly B; Ayers, Gregory D; Yan, Chi; Kelley, Mark C; Kauffmann, Rondi M; Hooks, Mary; Grau, Ana; Johnson, Douglas B; Vilgelm, Anna E; Richmond, Ann